SEC Tracker
Get the app

Annovis Bio ANVS

Annovis Bio offers shares and warrants

Securities offering

Form
424B5
Filed
Importance
Routine
  1. Offering shares of common stock and accompanying warrants
  2. Pre-funded warrants offered to investors exceeding 4.99% ownership
  3. Warrants expire in 5 years with exercise price of $ per share
  4. No established market for pre-funded warrants or warrants

Written from the 424B5 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Annovis Bio files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Abvc Biopharma ABVC public float $37M, Jun 30, 2025
  2. Karyopharm Therapeutics KPTI public float $37M, Jun 30, 2025
  3. Grace Therapeutics GRCE public float $35M, Sep 30, 2025
  4. BriaCell Therapeutics BCTX public float $37M, Jan 30, 2026
  5. Atara Biotherapeutics ATRA public float $39M, Jun 30, 2025